Icosapent Ethyl | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Icosapent Ethyl
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Icosapent Ethyl

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 25 USDMF, 10 JDMF, 1 KDMF, 9 Listed Suppliers, $ API Reference Price

31 API Suppliers
25 USDMF
10 JDMF
1 KDMF
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

82 Drugs in Development

82 Drugs in Development

FINISHED DOSAGE FORMULATIONS

30 FDF Dossiers, 20 FDA Orange Book, 2 Europe, 1 Canada, 1 Australia, 6 Listed Dossiers

30 FDF Dossiers
20 FDA Orange Book
2 Europe
1 Canada
1 Australia
6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 3 Rochem International Inc, 2 SPI Pharma, 9 DKSH, 1 Pharm-RX Chemical, 2 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 3 Lonza Capsugel, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Qualicaps, 14 Roquette, 6 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 2 Zhejiang Huakang Pharmaceutical

2 EUROAPI
1 Evonik
3 Rochem International Inc
2 SPI Pharma
9 DKSH
1 Pharm-RX Chemical
2 Gangwal Healthcare
5 Nanjing Well Pharmaceutical
1 Pfanstiehl
5 Kirsch Pharma
4 ACG Worldwide
6 Actylis
1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
2 BASF
1 Bioplus Life Sciences
2 CD Formulation
1 Finar
7 Gangwal Chemicals
1 Ideal Cures
3 Lonza Capsugel
1 Nanjing Bold Chemical
3 Pluviaendo
1 Qualicaps
14 Roquette
6 Seppic
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries
1 Valens Pharmachem
2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

19 Parenteral, 15 Thickeners and Stabilizers, 14 Solubilizers, 14 Fillers, Diluents & Binders, 14 Film Formers & Plasticizers, 13 Taste Masking, 10 Topical, 10 Coating Systems & Additives, 8 Empty Capsules, 7 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 3 Direct Compression, 3 Surfactant & Foaming Agents, 3 Coloring Agents, 3 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 2 Lubricants & Glidants, 2 API Stability Enhancers, 1 Rheology Modifiers, 1 Controlled & Modified Release, 1 Soft Gelatin

19 Parenteral
15 Thickeners and Stabilizers
14 Solubilizers
14 Fillers, Diluents & Binders
14 Film Formers & Plasticizers
13 Taste Masking
10 Topical
10 Coating Systems & Additives
8 Empty Capsules
7 Emulsifying Agents
5 Chewable & Orodispersible Aids
3 Direct Compression
3 Surfactant & Foaming Agents
3 Coloring Agents
3 Co-Processed Excipients
3 Disintegrants & Superdisintegrants
2 Lubricants & Glidants
2 API Stability Enhancers
1 Rheology Modifiers
1 Controlled & Modified Release
1 Soft Gelatin

DIGITAL CONTENT

161 News #PharmaBuzz

161 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 2 Regulatory FDF Prices

8 US Medicaid Prescriptions
2 Regulatory FDF Prices

MARKET PLACE

22 APIs

22 APIs

PATENTS & EXCLUSIVITIES

128 US Patents, 13 Health Canada Patents

128 US Patents
13 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 2 JP, 3 Others

1 EDQM
2 JP
3 Others

$ API Ref.Price (USD/KG) : 182 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

13 All

01 6Smart & Biggar

02 7Smart & Biggar LLP

filter Patent Reset all filters

13 All

01 12570763

02 12571462

03 12653787

04 12751576

05 12759284

06 12772378

07 13008079

08 13026006

09 13042062

10 13043081

11 13067008

12 13067012

13 13089847

filter Product Reset all filters

13 All

01 13ICOSAPENT ETHYL

filter Dosage Reset all filters

13 All

01 13CAPSULE

filter Exp Date Reset all filters

13 All

01 12026-07-07

02 12026-07-14

03 12027-05-31

04 32030-02-09

05 12030-04-29

06 22030-06-15

07 12031-03-04

08 22033-06-28

09 12039-04-22

Product Main Page

01

Smart & Biggar LLP

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar LLP

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-04

Date Granted : 2020-02-11

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 3043081

Filing Date : 2011-03-04

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-03-04

Date Granted : 2020-02-11

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Smart & Biggar LLP

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar LLP

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-02-09

Date Granted : 2020-09-22

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 3008079

Filing Date : 2010-02-09

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-02-09

Date Granted : 2020-09-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Smart & Biggar

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-07

Date Granted : 2011-08-23

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 2570763

Filing Date : 2006-07-07

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-07-07

Date Granted : 2011-08-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Smart & Biggar

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-14

Date Granted : 2013-08-13

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 2571462

Filing Date : 2006-07-14

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-07-14

Date Granted : 2013-08-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Smart & Biggar

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-05-31

Date Granted : 2016-06-21

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 2653787

Filing Date : 2007-05-31

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-05-31

Date Granted : 2016-06-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Smart & Biggar

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-02-09

Date Granted : 2018-07-03

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 2751576

Filing Date : 2010-02-09

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-02-09

Date Granted : 2018-07-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Smart & Biggar

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-04-29

Date Granted : 2016-06-21

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 2759284

Filing Date : 2010-04-29

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-04-29

Date Granted : 2016-06-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Smart & Biggar

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-06-15

Date Granted : 2019-04-02

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 2772378

Filing Date : 2010-06-15

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-06-15

Date Granted : 2019-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Smart & Biggar LLP

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar LLP

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-06-15

Date Granted : 2021-09-07

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 3026006

Filing Date : 2010-06-15

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-06-15

Date Granted : 2021-09-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Smart & Biggar LLP

Icosapent Ethyl

Pharmaconex

Not Confirmed

Smart & Biggar LLP

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-28

Date Granted : 2021-10-05

Icosapent Ethyl

Brand Name : VASCEPA

Patent Number : 3067012

Filing Date : 2013-06-28

Strength per Unit : 1 g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-06-28

Date Granted : 2021-10-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!